88 related articles for article (PubMed ID: 8951192)
1. The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine.
Snoeck E; Jacqmin P; Van Peer A; Danhof M; Ver Donck K; Van Belle H; Woestenborghs R; Crabbé R; Van Gool R; Dupont A; Heykants J
Br J Clin Pharmacol; 1996 Nov; 42(5):605-13. PubMed ID: 8951192
[TBL] [Abstract][Full Text] [Related]
2. Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates.
Snoeck E; Piotrovskij V; Jacqmin P; Van Peer A; Danhof M; Ver Donck K; Woestenborghs R; Van Belle H; Van Bortel L; Van Gool R; Dupont AG; Heykants J
Br J Clin Pharmacol; 1997 Jun; 43(6):603-12. PubMed ID: 9205820
[TBL] [Abstract][Full Text] [Related]
3. Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations.
Snoeck E; Piotrovskij V; Jacqmin P; Lins RL; Van Peer A; Danhof M; Woestenborghs R; Van Gool R; Dupont AG; Heykants J
Eur J Clin Pharmacol; 1997; 53(1):57-63. PubMed ID: 9349931
[TBL] [Abstract][Full Text] [Related]
4. Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine.
Snoeck E; Ver Donck K; Jacqmin P; Van Belle H; Dupont AG; Van Peer A; Danhof M
J Pharmacol Exp Ther; 1998 Jul; 286(1):142-9. PubMed ID: 9655853
[TBL] [Abstract][Full Text] [Related]
5. A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine.
Snoeck E; Jacqmin P; Van Peer A; Danhof M
J Pharmacokinet Biopharm; 1999 Jun; 27(3):257-81. PubMed ID: 10728489
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection.
Rongen GA; Smits P; Ver Donck K; Willemsen JJ; De Abreu RA; Van Belle H; Thien T
J Clin Invest; 1995 Feb; 95(2):658-68. PubMed ID: 7860749
[TBL] [Abstract][Full Text] [Related]
7. Studies of the nucleoside transporter inhibitor, draflazine, in the human myocardium.
Böhm M; Weinhold C; Schwinger RH; Müller-Ehmsen J; Böhm D; Reichenspurner H; Reichart B; Erdmann E
Br J Pharmacol; 1994 May; 112(1):137-42. PubMed ID: 8032635
[TBL] [Abstract][Full Text] [Related]
8. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016.
Beukers MW; Kerkhof CJ; IJzerman AP; Soudijn W
Eur J Pharmacol; 1994 Jan; 266(1):57-62. PubMed ID: 8137884
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
[TBL] [Abstract][Full Text] [Related]
11. Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1).
Vlachodimou A; Konstantinopoulou K; IJzerman AP; Heitman LH
Biochem Pharmacol; 2020 Feb; 172():113747. PubMed ID: 31830468
[TBL] [Abstract][Full Text] [Related]
12. High-grade nucleoside transport inhibition stimulates ventilation in humans.
Rongen GA; Smits P; Bootsma G; Ver Donck K; de Vries A; Thien T
J Clin Pharmacol; 1995 Apr; 35(4):357-61. PubMed ID: 7650223
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nucleoside transport binding sites in rabbit iris-ciliary body and cultured rabbit nonpigmented ciliary epithelial cells.
Williams EF; Chu TC; Socci RR; Brown LG; Walker CE; Manor EL
J Ocul Pharmacol Ther; 1996; 12(4):461-9. PubMed ID: 8951682
[TBL] [Abstract][Full Text] [Related]
14. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA
J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427
[TBL] [Abstract][Full Text] [Related]
16. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside transport inhibition by draflazine in unstable coronary disease.
Andersen K; Dellborg M; Swedberg K
Eur J Clin Pharmacol; 1996; 51(1):7-13. PubMed ID: 8880045
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration.
Tiseo PJ; Rogers SL; Friedhoff LT
Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):13-8. PubMed ID: 9839760
[TBL] [Abstract][Full Text] [Related]
19. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.
Shank RP; Doose DR; Streeter AJ; Bialer M
Epilepsy Res; 2005 Feb; 63(2-3):103-12. PubMed ID: 15715969
[TBL] [Abstract][Full Text] [Related]
20. Role of nucleoside transport inhibition and endogenous adenosine in prevention of catecholamine induced death in rabbits.
Van Belle H; Ver Donck K; Verheyen W
Cardiovasc Res; 1993 Jan; 27(1):111-5. PubMed ID: 8458020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
